Abstract:Background The Cancer Genome Atlas (TCGA) project has shed light on the vital role of tumour molecular features in predicting endometrial cancer (EC) patients’ survival. This study aims to investigate the survival impact of surgical approaches on EC patients with different molecular features. Methodology 473 eligible EC patients from TCGA database were selected. Clinicopathological characteristics and genetic features of open and minimally invasive surgery (MIS) group were compared. To analyse the prognostic impact of surgical approach, survival analyses were conducted in patients with different genetic alterations. Finally, a simplified model based on molecular features was established to help select patients suitable for MIS or open surgery. Results In the eligible patients, 291 (61.5%) received open surgery and 182 (38.5%) received MIS. Clinicopathological and genetic features were comparable between the two groups except the year of diagnosis (p<0.001). Among all patients, 4 genetic features (POLE mutation [POLEmt], microsatellite-instability high [MSI-H], homologous recombination defect [HRD], MUC16 mutation [MUC16mt]) showed significant overlap. In Kaplan-Meier survival analyses, MIS and open surgery brought similar survival outcome in patients with POLEmt, MSI-H, HRD or MUC16mt. But in POLE wild type, non MSI-H, non HRD, or MUC16 wild type patients, MIS resulted in shorter recurrence-free survival (RFS) (p=0.008, 0.015, 0.003, 0.008). Based on TCGA classification, POLE ultramutated and MSI hypermutated type had similar prognosis after two surgeries, while copy-number low type without CTNNB1 mutation and copy-number high type with TP53 mutation showed more rapid recurrence after MIS (p=0.048 and 0.037). Further analyses were done to simplify the model. In patients with ≥1 of the 4 features (POLEmt, MSI-H, HRD or MUC16mt), MIS and open surgery brought comparable overall survival and RFS (p=0.339 and 0.969); for patients with none of the features, especially those with wild type CTNNB1 or TP53 mutation, longer RFS was observed in open surgery group (p=0.001, <0.001, <0.001, respectively). All the results of Kaplan-Meier analyses were verified by Cox regressions. Conclusion The molecular features of EC are related to patients’ prognosis after different surgical approaches. MIS should be recommended in patients with POLEmt, MSI-H, HRD or MUC16mt for similar survival outcome and less perioperative complications compared to open surgery. Disclosures This work was supported by the National Natural Science Foundation of China (81972426, 81202041, 81672571, 81874108 and 81802607), Special Projects for Strengthening Basic Research of Peking University (BMU2018JC005), National Key Technology R&D Program of China (2019YFC1005200 and 2019YFC1005201). The authors have no potential conflict of interest to disclose.

Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data

88 Tumour Molecular Features Predict Endometrial Cancer Patients‘ Survival after Different Surgical Approaches

Survival after Radical Cystectomy for Bladder Cancer: Multicenter Comparison Between Minimally Invasive and Open Approaches

Tumor Molecular Features Predict Endometrial Cancer Patients' Survival after Open or Minimally Invasive Surgeries.

Survival rates of patients who undergo minimally invasive surgery for endometrial cancer with cervical involvement

Minimally invasive surgery for patients with advanced stage endometrial cancer

Minimally invasive surgery versus open surgery in high-risk histologic endometrial cancer patients: A meta-analysis

Application and evaluation of minimally invasive surgical treatment options for early endometrial cancer

Impact of surgical approach on progress of disease by type of histology in stage IA endometrial cancer: a matched-pair analysis

Surgical Treatment for Endometrial Cancer, Hysterectomy Performed via Minimally Invasive Routes Compared with Open Surgery: A Systematic Review and Network Meta-Analysis

Minimally invasive surgery does not impair overall survival in stage IIIC endometrial cancer patients

Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer

Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan

Comparison of survival and complications between minimally invasive and open staging surgeries in non-endometrioid endometrial cancer

Impact of surgical approach on prevalence of positive peritoneal cytology and lymph-vascular invasion in patients with early-stage endometrial carcinoma: a National Cancer Database study

Mismatch repair status and surgical approach in apparent early-stage endometrial cancer

Minimally Invasive Compared With Open Surgery in High-Risk Endometrial Cancer: A Systematic Review and Meta-analysis

Survival benefit of surgical treatment for patients with stage IVB endometrial cancer: a propensity score-matched SEER database analysis

Abstract B022: Conversion from minimally invasive surgical approaches to open surgery among endometrial cancer patients in a national cancer patients' registry

Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: A real‐world multicenter study of a large Chinese cohort from 2006 to 2017

Minimally Invasive Surgery in High-Grade Endometrial Carcinoma and Risk for Local Recurrence: An Israeli Gynecology Oncology Group Study